ZNF385A Antikörper (N-Term)
Kurzübersicht für ZNF385A Antikörper (N-Term) (ABIN1109584)
Target
Alle ZNF385A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- EPAPTLGLFS NYSTMDPVQK AVLSHTFGGP LLKTKRPVIS CNICQIRFNS
-
Kreuzreaktivität (Details)
- Species reactivity (expected):Mouse, Rat, BovineSpecies reactivity (tested):Human
-
Aufreinigung
- Purified using peptide immunoaffinity column
-
Immunogen
- The immunogen for anti-ZNF385 antibody: synthetic peptide directed towards the N terminal of human ZNF385
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Add 50 μL of distilled water to a final concentration of 1 mg/mL.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
-
- ZNF385A (Zinc Finger Protein 385A (ZNF385A))
-
Andere Bezeichnung
- ZNF385A
-
Hintergrund
- ZNF385 is a 322 amino acid 38 kDa protein containing 3 matrin-type zinc fingers. It is expressed predominantly in the retina and may be involved in transcriptional regulation.Synonyms: HZF, Hematopoietic zinc finger protein, RZF, Retinal zinc finger protein, ZNF385, Zinc finger protein 385A
-
Gen-ID
- 25946
-
NCBI Accession
- NP_056296
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus, Negative Regulation of intrinsic apoptotic Signaling, Positive Regulation of fat Cell Differentiation
Target
-